Loading clinical trials...
Loading clinical trials...
A Randomized Phase III Study of 5-Fluorouracil-based Regimen With or Without Oxaliplatin as 2nd Line Treatment of Advanced or Metastatic Pancreatic Cancer in Patients Who Have Previously Received Gemcitabine-based Chemotherapy
Conditions
Interventions
Leucovorin
OXALIPLATIN
+1 more
Locations
15
Canada
Investigational Site Number 124015
Abbotsford, Canada
Investigational Site Number 124018
Brampton, Canada
Investigational Site Number 124014
Burnaby, Canada
Investigational Site Number 124006
Calgary, Canada
Investigational Site Number 124008
Greater Sudbury, Canada
Investigational Site Number 124011
Greenfield Park, Canada
Start Date
July 1, 2010
Primary Completion Date
October 1, 2013
Completion Date
October 1, 2013
Last Updated
October 27, 2014
NCT06885697
NCT07139236
NCT07035587
NCT06953193
NCT05218889
NCT06538623
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions